214 related articles for article (PubMed ID: 25866158)
1. Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein.
Tateno H; Onuma Y; Ito Y; Minoshima F; Saito S; Shimizu M; Aiki Y; Asashima M; Hirabayashi J
Stem Cell Reports; 2015 May; 4(5):811-20. PubMed ID: 25866158
[TBL] [Abstract][Full Text] [Related]
2. Engineering of a Potent Recombinant Lectin-Toxin Fusion Protein to Eliminate Human Pluripotent Stem Cells.
Tateno H; Saito S
Molecules; 2017 Jul; 22(7):. PubMed ID: 28698527
[TBL] [Abstract][Full Text] [Related]
3. Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.
Della Cristina P; Castagna M; Lombardi A; Barison E; Tagliabue G; Ceriotti A; Koutris I; Di Leandro L; Giansanti F; Vago R; Ippoliti R; Flavell SU; Flavell DJ; Colombatti M; Fabbrini MS
Microb Cell Fact; 2015 Feb; 14():19. PubMed ID: 25889802
[TBL] [Abstract][Full Text] [Related]
4. Expression and Purification of a Human Pluripotent Stem Cell-Specific Lectin Probe, rBC2LCN.
Tateno H
Methods Mol Biol; 2020; 2132():453-461. PubMed ID: 32306352
[TBL] [Abstract][Full Text] [Related]
5. [Soluble expression of recombinant immunotoxin against human bladder carcinoma and its anti-tumor activity].
Chao K; He D; Yang H; Zhang Z; Lin Q; Guo AG; Huang HL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):568-71. PubMed ID: 15367349
[TBL] [Abstract][Full Text] [Related]
6. Lectin drug conjugate therapy for colorectal cancer.
Kitaguchi D; Oda T; Enomoto T; Ohara Y; Owada Y; Akashi Y; Furuta T; Yu Y; Kimura S; Kuroda Y; Kurimori K; Miyazaki Y; Furuya K; Shimomura O; Tateno H
Cancer Sci; 2020 Dec; 111(12):4548-4557. PubMed ID: 33058342
[TBL] [Abstract][Full Text] [Related]
7. Oriented immobilization of rBC2LCN lectin for highly sensitive detection of human pluripotent stem cells using cell culture supernatants.
Tateno H; Hiemori K; Minoshima F; Kiyoi K; Matoba K; Katayama J; Kumada Y
J Biosci Bioeng; 2020 Feb; 129(2):215-222. PubMed ID: 31473147
[TBL] [Abstract][Full Text] [Related]
8. Live-cell imaging of human pluripotent stem cells by a novel lectin probe rBC2LCN.
Tateno H; Onuma Y; Ito Y
Methods Mol Biol; 2014; 1200():313-8. PubMed ID: 25117245
[TBL] [Abstract][Full Text] [Related]
9. Antibody internalization studied using a novel IgG binding toxin fusion.
Mazor Y; Barnea I; Keydar I; Benhar I
J Immunol Methods; 2007 Apr; 321(1-2):41-59. PubMed ID: 17336321
[TBL] [Abstract][Full Text] [Related]
10. Podocalyxin is a glycoprotein ligand of the human pluripotent stem cell-specific probe rBC2LCN.
Tateno H; Matsushima A; Hiemori K; Onuma Y; Ito Y; Hasehira K; Nishimura K; Ohtaka M; Takayasu S; Nakanishi M; Ikehara Y; Nakanishi M; Ohnuma K; Chan T; Toyoda M; Akutsu H; Umezawa A; Asashima M; Hirabayashi J
Stem Cells Transl Med; 2013 Apr; 2(4):265-73. PubMed ID: 23526252
[TBL] [Abstract][Full Text] [Related]
11. Anthrax toxin-mediated delivery of the Pseudomonas exotoxin A enzymatic domain to the cytosol of tumor cells via cleavable ubiquitin fusions.
Bachran C; Morley T; Abdelazim S; Fattah RJ; Liu S; Leppla SH
mBio; 2013 Apr; 4(3):e00201-13. PubMed ID: 23631917
[TBL] [Abstract][Full Text] [Related]
12. Photoactivable Elimination of Tumorigenic Human Induced Pluripotent Stem Cells by Using a Lectin-Doxorubicin Prodrug Conjugate.
Dion J; Minoshima F; Saito S; Kiyoi K; Hasehira K; Tateno H
Chembiochem; 2019 Jun; 20(12):1606-1611. PubMed ID: 30737871
[TBL] [Abstract][Full Text] [Related]
13. Engineering of bacterial exotoxins for highly efficient and receptor-specific intracellular delivery of diverse cargos.
Ryou JH; Sohn YK; Hwang DE; Park WY; Kim N; Heo WD; Kim MY; Kim HS
Biotechnol Bioeng; 2016 Aug; 113(8):1639-46. PubMed ID: 26773973
[TBL] [Abstract][Full Text] [Related]
14. A medium hyperglycosylated podocalyxin enables noninvasive and quantitative detection of tumorigenic human pluripotent stem cells.
Tateno H; Onuma Y; Ito Y; Hiemori K; Aiki Y; Shimizu M; Higuchi K; Fukuda M; Warashina M; Honda S; Asashima M; Hirabayashi J
Sci Rep; 2014 Feb; 4():4069. PubMed ID: 24518842
[TBL] [Abstract][Full Text] [Related]
15. Molecular construction and characterization of a novel exotoxin fusion protein that selectively blocks the B7:CD28 costimulatory signal system.
Xi Y; Yuan Z; Zhang H; Guan H; Kong F; Liu N; Liang F; Cui J; Guo S; Sun Y; Xi C
J Immunother; 2006; 29(6):586-95. PubMed ID: 17063121
[TBL] [Abstract][Full Text] [Related]
16. Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells.
Arora N; Klimpel KR; Singh Y; Leppla SH
J Biol Chem; 1992 Aug; 267(22):15542-8. PubMed ID: 1639793
[TBL] [Abstract][Full Text] [Related]
17. A novel fusion toxin derived from an EpCAM-specific designed ankyrin repeat protein has potent antitumor activity.
Martin-Killias P; Stefan N; Rothschild S; Plückthun A; Zangemeister-Wittke U
Clin Cancer Res; 2011 Jan; 17(1):100-10. PubMed ID: 21075824
[TBL] [Abstract][Full Text] [Related]
18. Codon optimization enhances secretory expression of Pseudomonas aeruginosa exotoxin A in E. coli.
Wang X; Li X; Zhang Z; Shen X; Zhong F
Protein Expr Purif; 2010 Jul; 72(1):101-6. PubMed ID: 20172029
[TBL] [Abstract][Full Text] [Related]
19. Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion.
Park S; Nguyen MQ; Ta HKK; Nguyen MT; Lee G; Kim CJ; Jang YJ; Choe H
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204265
[TBL] [Abstract][Full Text] [Related]
20. Expression and purification of recombinant immunotoxin--a fusion protein stabilizes a single-chain Fv (scFv) in denaturing condition.
Kim SH
Protein Expr Purif; 2003 Jan; 27(1):85-9. PubMed ID: 12509988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
